Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study

Tumor mutation burden (TMB) is an independent indicator used to select patients sensitive to immunotherapy. The present study aimed to investigate the clinicopathological and molecular characteristics of patients with hypermutant lung cancer to identify an economical, simple and complementary method...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Lett
Main Authors: Zhang, Hongbin, Wang, Yuan, Ji, Qiaoxia, Cai, Hongmei, Liang, Xiangcun, Xie, Jiong, Li, Hua, Wang, Jun, Zhu, Guiyun, Tian, Erpeng, Zhu, Lingling, Yuan, Mingming, Chen, Rongrong, Zhao, Min
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2021
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933761/
https://ncbi.nlm.nih.gov/pubmed/33692861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12590
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items